Tal Zeeli
Tel Aviv, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Lichen planus pemphigoides following COVID-19 infection.
Journal: JAAD case reports
Published: May 01, 2024
Coexistence of malignancies in pemphigus vulgaris.
Journal: Immunologic research
Published: December 18, 2022
Relationship Between Pemphigus Vulgaris Severity and PCR-positive Herpes Simplex Virus.
Journal: Acta dermato-venereologica
Published: April 08, 2022
Phase 2 BELIEVE study part B: Efficacy and safety of rilzabrutinib for patients with pemphigus vulgaris.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: November 22, 2021
Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE study.
Journal: The British journal of dermatology
Published: April 30, 2021
Superimposed type 2 segmental atopic dermatitis: case series and review of the literature.
Journal: Clinical and experimental dermatology
Published: May 09, 2020
Bullous pemphigoid distributed above the injury level in a paraplegic patient.
Journal: Clinical and experimental dermatology
Published: November 19, 2019
Mucous membrane pemphigoid-otorhinolaryngological manifestations: a retrospective cohort study.
Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Published: September 03, 2019
Grover disease and bullous pemphigoid: a clinicopathological study of six cases.
Journal: Clinical and experimental dermatology
Published: June 04, 2018
Bullous pemphigoid and diabetes mellitus: Are we missing the larger picture?
Journal: Journal of the American Academy of Dermatology
Published: January 16, 2018
Last Updated: 09/26/2026